Selective decontamination of the digestive tract (SDD) in critically ill patients: a narrative review

被引:64
|
作者
Wittekamp, Bastiaan H. J. [1 ]
Oostdijk, Evelien A. N. [2 ]
Cuthbertson, Brian H. [2 ]
Brun-Buisson, Christian [3 ]
Bonten, Marc J. M. [4 ,5 ]
机构
[1] Univ Utrecht, Univ Med Ctr Utrecht, Dept Intens Care, Utrecht, Netherlands
[2] Univ Toronto, Univ Dept Anesthesiol & Pain Med, Dept Crit Care Med, Toronto, ON, Canada
[3] Inst Pasteur, Inserm UVSQ, Biostat Biomath Pharmacoepidemiol & Infect Dis B2, Paris, France
[4] Univ Utrecht, Univ Med Ctr Utrecht, Dept Med Microbiol, Utrecht, Netherlands
[5] Univ Utrecht, Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, Utrecht, Netherlands
关键词
Selective decontamination; Infection prevention; Antibiotic resistance; INTENSIVE-CARE UNITS; ANTIMICROBIAL RESISTANCE; DOUBLE-BLIND; OROPHARYNX; COLONIZATION; FLORA;
D O I
10.1007/s00134-019-05883-9
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Selective decontamination of the digestive tract (SDD) is an infection prevention measure for intensive care unit (ICU) patients that was proposed more than 30 years ago, and that is currently considered standard of care in the Netherlands, but only used sporadically in ICUs in other countries. In this narrative review, we first describe the rationale of the individual components of SDD and then review the evidence base for patient-centered outcomes, where we distinguish ICUs with low prevalence of antibiotic resistance from ICUs with moderate-high prevalence of resistance. In settings with low prevalence of antibiotic resistance, SDD has been associated with improved patient outcome in three cluster-randomized studies. These benefits were not confirmed in a large international cluster-randomized study in settings with moderate-to-high prevalence of antibiotic resistance. There is no evidence that SDD increases antibiotic resistance. We end with future directions for research.
引用
收藏
页码:343 / 349
页数:7
相关论文
共 50 条
  • [31] INFECTION PREVENTION WITH SELECTIVE DIGESTIVE TRACT DECONTAMINATION (SDD) IN PATIENTS WITH A VENTRICULAR ASSIST DEVICE (VAD)
    Martin Amador, S. R.
    Jorge Luis, R. L.
    Juan Antonio, C. G.
    Miguel, S. G.
    INTENSIVE CARE MEDICINE, 2014, 40 : S227 - S228
  • [32] Selective Digestive Decontamination Attenuates Organ Dysfunction in Critically Ill Burn Patients
    Lopez-Rodriguez, Lucia
    de la Cal, Miguel A.
    Garcia-Hierro, Paloma
    Herrero, Raquel
    Martins, Judith
    van Saene, Hendrick K. F.
    Lorente, Jose A.
    SHOCK, 2016, 46 (05): : 492 - 497
  • [33] Selective Digestive Decontamination Is Neither Safe Nor Efficacious for Critically Ill Patients
    Hurley, James C.
    CRITICAL CARE MEDICINE, 2020, 48 (05) : 732 - 735
  • [34] HOW TO IMPROVE INFECTION PREVENTION BY SELECTIVE DECONTAMINATION OF THE DIGESTIVE-TRACT (SDD)
    STOUTENBEEK, CP
    VANSAENE, HKF
    INFECTION, 1990, 18 : S10 - S13
  • [35] Does selective decontamination of the digestive tract reduce mortality for severely ill patients?
    Sun, XL
    Wagner, DP
    Knaus, WA
    CRITICAL CARE MEDICINE, 1996, 24 (05) : 753 - 755
  • [36] Selective decontamination of the digestive tract does not increase resistance in critically ill patients: Evidence from randomized controlled trials
    Silvestri, L
    van Saene, HKF
    CRITICAL CARE MEDICINE, 2006, 34 (07) : 2027 - 2029
  • [37] Presence of tobramycin in blood and urine during selective decontamination of the digestive tract in critically ill patients, a prospective cohort study
    Heleen M Oudemans-van Straaten
    Henrik Endeman
    Robert J Bosman
    Milly E Attema-de Jonge
    Marc L van Ogtrop
    Durk F Zandstra
    Eric JF Franssen
    Critical Care, 15
  • [38] Monitoring of tobramycin serum concentrations in selected critically ill patients receiving selective decontamination of the digestive tract: a retrospective evaluation
    Mohlmann, J. E.
    van Luin, M.
    Mascini, E. M.
    van Leeuwen, H. J.
    de Maat, M. R.
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2019, 75 (06) : 831 - 836
  • [39] Presence of tobramycin in blood and urine during selective decontamination of the digestive tract in critically ill patients, a prospective cohort study
    Oudemans-van Straaten, Heleen M.
    Endeman, Henrik
    Bosman, Robert J.
    Attema-de Jonge, Milly E.
    van Ogtrop, Marc L.
    Zandstra, Durk F.
    Franssen, Eric J. F.
    CRITICAL CARE, 2011, 15 (05): : R240
  • [40] Monitoring of tobramycin serum concentrations in selected critically ill patients receiving selective decontamination of the digestive tract: a retrospective evaluation
    J. E. Möhlmann
    M. van Luin
    E. M. Mascini
    H. J. van Leeuwen
    M. R. de Maat
    European Journal of Clinical Pharmacology, 2019, 75 : 831 - 836